These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 2438412)

  • 1. Structure and biology of Shigella flexneri O antigens.
    Simmons DA; Romanowska E
    J Med Microbiol; 1987 Jun; 23(4):289-302. PubMed ID: 2438412
    [No Abstract]   [Full Text] [Related]  

  • 2. [Bacterial antigenic structure of Shigella flexneri serotype 1B and its 3B serotype mutant and susceptibility to bacterial action of complement in normal bovine serum].
    Doroszkiewicz W; Lachowicz TM
    Postepy Hig Med Dosw; 1996; 50(5):519-23. PubMed ID: 9072769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of antigenic variation in Shigella flexneri bacilli. IV. Role of lipopolysaccharides and their components in the sensitivity of Shigella flexneri 1b and its Lac+ recombinant to killing action of serum.
    Doroszkiewicz W
    Arch Immunol Ther Exp (Warsz); 1997; 45(2-3):235-42. PubMed ID: 9597093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. On the antigenic relationship of "Vibrio cholerae" to "Enterobacteriaceae".
    Winkle S; Refai M; Rohde R
    Ann Inst Pasteur (Paris); 1972 Dec; 123(6):775-81. PubMed ID: 4570333
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunochemical characteristics of Shigella sonnei and serotype 6 Shigella flexneri lipopolysaccharides and enterobacterial common antigen.
    Romanowska E; Katzenellenbogen E; Lugowski C; Gamian A; Bogulska M
    Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):249-54. PubMed ID: 86336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Chemical and serological study of lipopolysaccharide isolated from Shigella flexneri 88-893 possessing a new type-antigen].
    Toshima Y; Iguchi T; Kondo S; Matsushita S; Kudoh Y; Hisatsune K
    Nihon Saikingaku Zasshi; 1992 Nov; 47(6):777-81. PubMed ID: 1484404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The chemical basis of the Shigella flexneri-O-antigens.
    Seltmann G; Beer W
    J Hyg Epidemiol Microbiol Immunol; 1974; 18(4):397-404. PubMed ID: 4616052
    [No Abstract]   [Full Text] [Related]  

  • 8. Mechanism of antigenic variation in Shigella flexneri bacilli. I. Selective lethal effect of normal sera on mixed population of S. flexneri 1b serotype and its antigenic 3b mutant.
    Doroszkiewicz W; Lachowicz TM
    Arch Immunol Ther Exp (Warsz); 1989; 37(5-6):693-701. PubMed ID: 2487379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Studies on the antigenic structure of Shigella. VII. Binding of N-acetyl-glucosamine in O-specific side chains of lipopolysaccharides in Shigella flexneri 1b and variant Y].
    Seltmann G; Beer W
    Z Allg Mikrobiol; 1972; 12(5):423-33. PubMed ID: 4564837
    [No Abstract]   [Full Text] [Related]  

  • 10. HeLa cell invasiveness and O antigen of Shigella flexneri as separate and prerequisite attributes of virulence to evoke keratoconjunctivitis in guinea pigs.
    Okamura N; Nagai T; Nakaya R; Kondo S; Murakami M; Hisatsune K
    Infect Immun; 1983 Feb; 39(2):505-13. PubMed ID: 6187681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antigenic variability of Shigella flexneri serovars 1-5.
    Petrovskaya VG; Bondarenko VM
    Mol Gen Mikrobiol Virusol; 1995; (2):15-7. PubMed ID: 7477027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Intergeneric antigenic relation of Hafnia and Shigella (S. flexneri and S. boydii) bacteria].
    Baturo AP
    Zh Mikrobiol Epidemiol Immunobiol; 1986 Sep; (9):19-21. PubMed ID: 2431565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural and immunochemical studies of the lipopolysaccharide from a new provisional serotype of Shigella flexneri.
    Wehler T; Carlin NI
    Eur J Biochem; 1988 Sep; 176(2):471-6. PubMed ID: 2458260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure of the O-antigen of a novel Shigella flexneri serotype, 1d (I: 7,8).
    Shashkov AS; Senchenkova SN; Sun Q; Lan R; Wang J; Perepelov AV; Knirel YA; Xu J
    Carbohydr Res; 2013 May; 373():93-6. PubMed ID: 23603189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A reinvestigation of Shigella flexneri O-antigens by methylation analysis.
    Lindberg B; Lönngren J; Rudén U; Simmons DA
    Eur J Biochem; 1973 Jan; 32(1):15-8. PubMed ID: 4119910
    [No Abstract]   [Full Text] [Related]  

  • 16. Genetic and biosynthetic aspects of Shigella flexneri O-specific lipopolysaccharides.
    Simmons DA
    Biochem Soc Trans; 1993 Feb; 21(1):58S. PubMed ID: 7680623
    [No Abstract]   [Full Text] [Related]  

  • 17. [Genetic characteristics and trends in the spread of a new Shigella flexneri subserovar with the antigenic formula IV:7,8].
    Bondarenko VM; Petrovskaia VG; Priamukhina NS; Bobrova TP
    Zh Mikrobiol Epidemiol Immunobiol; 1987 Feb; (2):42-6. PubMed ID: 2437740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. O-antigen modifications providing antigenic diversity of Shigella flexneri and underlying genetic mechanisms.
    Knirel YA; Sun Q; Senchenkova SN; Perepelov AV; Shashkov AS; Xu J
    Biochemistry (Mosc); 2015 Jul; 80(7):901-14. PubMed ID: 26542003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Shigella flexneri serotype Y vaccine candidate SFL124 originated from a serotype 2a background.
    Roberts F; Jennison AV; Verma NK
    FEMS Immunol Med Microbiol; 2005 Aug; 45(2):285-9. PubMed ID: 15963704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of some Shigella flexneri (Escherichia coli) hybrids in cross agglutination and agglutinin absorption tests.
    Lachowicz TM; Lagowska-Złotorzycka M; Czarny A; Kołodyński J
    Arch Immunol Ther Exp (Warsz); 1979; 27(5):693-9. PubMed ID: 398206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.